Equity markets are making a comeback this week after several governments announced a slew of economic measures to fight COVID-19. In the last three days, the iShares S&P/TSX 60 Index has gained close to 20%. This recovery has driven stocks of a number of companies higher. Several marijuana stocks are roaring back to life as well after a disappointing 2019.…
Read More
Relief measures saw the TSX bounce 7% Tuesday. However, safe investments are still the order of the day. The country’s biggest stock exchange is still down by 5% on average for the past five days of trading. Value opportunities will be abundant in the coming weeks, so get out those watch lists. Investors could consider adding shares in stages, owning…
Read More
Pot stocks were crushed during the 2019 marijuana downturn. The 2020 coronavirus pandemic has made a bad situation worse. Many investors are hoping that the coronavirus crash will be a brief affair. Encouraging data points from China and South Korea prove that the pandemic can be contained, but countries like the U.S. and Canada could be weeks or months away…
Read More
As cannabis legalization slowly continues to make its way through the United States and the rest of the world, cannabis stocks have continued to grow in demand. However, a surge in new cannabis companies looking to capitalize on the new “green rush” led to far too much saturation within the industry. This has led to an industry-wide slowdown, as the…
Read More
As we continue on in the 11th year of economic expansion since the financial crisis, many investors (myself included) believe we may be headed toward difficult times in the next 12-24 months. If the market continues to roll along, I will be dead wrong, but the long-gold, short-cannabis trade is one that I think represents shifting sentiments in the markets.…
Read More
The Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) stock price fell 18.3% in February. The market continues to fall and company-specific uncertainty remains high. This is making any prediction for the Cronos Group stock price very uncertain and precarious. Fears of the potential severity of the coronavirus have ruled the market since February. This certainly continues today. As I write this article, I…
Read More
Pot stocks were hammered in 2019. Nearly every company lost at least 50% of its value. Cannabis demand, on the other hand, continues to climb. This disconnect provides patient investors a clear path to profit. As with any early-stage market, investors scrambled at the chance to inject pent-up capital into cannabis companies. In 2018, many pot stocks rose by more…
Read More
For cannabis investors who continue to hold positions in any of Canada’s cannabis producers, every news cycle seems to bring unwanted negative news, driving volatility in the sector and valuations lower, as many take money off the table after a wild ride that has seen valuations reach astronomical levels. Determining what precisely has driven this volatility and scared many investors…
Read More
Industry-wide carnage instead of a boom in 2019 dealt a crushing blow to cannabis producers. The sector’s acknowledged production leader in particular tanked at blinding speed and lost value as a result. As of this writing, Aurora Cannabis (TSX:ACB)(NYSE:ACB) is trading at $2.06 per share, and the market capitalization stands at only $2.4 billion. In August 2019, Aurora was a…
Read More
The past two years have been a roller coaster ride for marijuana investors. In 2018, cannabis stocks were regularly doubling in price. In 2019, they were regularly halving in the price. Despite the whirlwind, the pot industry still has a strong decade of growth ahead of it. Cowen Inc, the leading voice on cannabis stocks, thinks that the U.S. will…
Read More